Up to one-third of pregnant women do not believe cannabis is harmful to their fetus, according to a new review by UBC researchers.
Cambridge researchers have discovered the placenta regulates how much oxygen and nutrients it transports to babies during challenging pregnancies in the first study of its kind. The placenta is one of the least understood human organs and it is notoriously difficult to study. This new research focused on analysing the placental mitochondria and it is hoped the new findings could lead to tests to determine whether a mother's placenta is functioning properly.
New study analyses the health impact of exposure to 21 non-persistent chemicals among pregnant women.
Sleeping more than nine hours per night during pregnancy may be associated with late stillbirth, a new Michigan Medicine-led international study suggests.
A new paper published in Pediatrics links successful implementation of Baby-Friendly™ practices in the southern US with increases in breastfeeding rates and improved, evidence-based care. The changes were especially positive for African-American women.
A new study from a Massachusetts General Hospital research team has found that the hypertension drug losartan, which targets the angiotensin signaling pathway, may improve the effectiveness of chemotherapy agents used to treat ovarian cancer.
If a pregnant woman gains excessive weight, it can pose a problem for both the mother and child. As a solution, regular counseling appointments have been proposed. Based on results with 2286 women, a team of the Technical University of Munich (TUM) in cooperation with the Competence Center for Nutrition (KErn) has now shown that although counseling appointments as part of routine prenatal care can encourage a healthier lifestyle, it does not reduce weight gain.
Two new mouse models of uterine cancer reveal that the TGF-beta signaling pathway in uterine cells protects against the disease by suppressing the overgrowth and oncogenesis of the endometrium, the membrane lining the inside of the uterus.
A new long-acting contraceptive designed to be self-administered by women may provide a new family planning option, particularly in developing nations where access to healthcare can be limited, a recent study suggests. The contraceptive would be delivered using microneedle skin patch technology originally developed for the painless administration of vaccines.
In one of the first needs assessments of its kind, Anne Sebert Kuhlmann, Ph.D., MPH, associate professor of behavioral science and health education at Saint Louis University's College for Public Health and Social Justice and her team have documented the challenges, from affordability to transportation, that low-income people with periods face in accessing basic sanitary supplies.